Autopsy report · NCT03662685

Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris

“Closing of the Goeckerman program at UCSF and loss of funding, PI left UCSF”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months before it started.
• Ran for about 5 years 10 months before it stopped.
• 4 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of California, San Francisco

Sponsor type

University, hospital or other

Conditions

Psoriasis Vulgaris; Psoriasis

Interventions

Goeckerman Therapy; Crude Coal Tar Only; Phototherapy Only

Participants

4

Sites

1

Countries

United States

Trials that died the same way

• Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
  “Funding and PI leaving institution” (61% match in meaning)
• Novel Gallium 68 Citrate in Orthopedic Infections
  “PI left the institute and the funding expired.” (59% match in meaning)
• Comparison of Quadratus Lumborum Block Types
  “PI left the institution. Decision made to close the study.” (59% match in meaning)
• Once Versus Twice Daily Iron Supplementation in Pregnant Women
  “Lack of funds, PI left University” (58% match in meaning)
• Qatar Universal Diabetes Outcomes (QUDOS) Study
  “The study has been closed by our IRB due to the PI's departure from the Institution.” (58% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.